glp 1 analogue market GLP-1 Analogues Size, Share & Forecast Report, 2026-2034 GLP-1 Receptor Agonist Market Size

Recent research suggests that medications for type 2 diabetes of the GLP-1 class, such as Ozempic or Mounjaro, could offer an additional benefit beyond glycemic control: reduce the risk of dangerous blood clots in people with diabetes.This finding represents a new potential advantage for those who use these treatments

These can vary depending on the pharmacy and are not always disclosed in detail on the front end

Because the human data is missing, "unstudied" is the operative word

S.SarkerP

:

Weight loss outcomes : Semaglutide at the doses used for weight management (Wegovy, 2.4 mg weekly) has produced average weight loss of 15-17% of body weight over 68 weeks in clinical trials (STEP program)